NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Cabaletta Bio, Inc. Common Stock Share Price Chart

O H L

Cabaletta Bio, Inc. Common Stock Performance Overview

Days Range
$2.53Low
$2.56High

Markets Today

Previous Close$2.58
Open$2.56
Volume353,866
Day's Range$2.53 - $2.56
52W Range$1.92 - $4.23
Market Cap$422.17 M

Historical Performance

1M Returns-11.34
3M Returns-9.15
6M Returns-13.13
1Y Returns+18.35
5Y Returns-79.16
10Y ReturnsNA

Cabaletta Bio, Inc. Common Stock Fundamentals

Market Cap$422.17 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.27
EPS TTM$-1.57
Quarterly Earnings Growth YOYN/A
PB Ratio1.98
EBITDA$-170.59 M
Profit MarginN/A
Market Cap$422.17 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-1.27
EPS TTM$-1.57
Quarterly Earnings Growth YOYN/A
PB Ratio1.98
EBITDA$-170.59 M
Profit MarginN/A

Cabaletta Bio, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$37.14 M-$45.97 M-$46.59 M-$42.61 M-$43.95 M-$52.10 M
EBITDA -$36.65 M-$45.50 M-$46.24 M-$42.26 M-$43.62 M-$51.73 M
Interest Expense -$294.00 K-$571.00 K-$584.00 K-$555.00 K-$636.00 K-$517.00 K
Depreciation $485.00 K$468.00 K$345.00 K$348.00 K$337.00 K$371.00 K
Income Before Tax -$35.94 M-$45.13 M-$44.87 M-$41.92 M-$43.52 M-$51.02 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$35.94 M-$45.13 M-$44.87 M-$41.92 M-$43.52 M-$51.02 M
Net Profit Margin ------

Cabaletta Bio, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.00 K$1.00 K$1.00 K$1.00 K$1.00 K$1.00 K
Reserve & Surplus -$385.04 M-$430.17 M-$475.01 M-$516.93 M-$560.47 M-$611.49 M
Non-Current Liabilities $9.60 M$4.48 M$4.56 M$2.88 M$3.33 M$6.22 M
Current Liabilities $33.99 M$41.54 M$45.73 M$50.15 M$41.51 M$39.91 M
Total Liabilities $43.59 M$46.02 M$50.29 M$53.03 M$44.84 M$46.13 M
Fixed Assets $2.64 M$2.37 M$2.06 M$1.92 M$1.58 M$1.48 M
Current Assets $134.60 M$198.41 M$164.56 M$138.87 M$122.32 M$231.03 M
Total Assets $165.14 M$224.50 M$189.76 M$165.08 M$148.15 M$256.73 M

Cabaletta Bio, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$35.94 M-$45.13 M-$44.87 M-$41.92 M-$43.52 M-$51.02 M
Operating Cash Flow -$30.80 M-$30.43 M-$34.51 M-$35.34 M-$42.56 M-$41.51 M
Investing Cash Flow -$785.00 K-$49.20 M-$50.08 M$49.80 M$50.96 M$0
Financing Cash Flow -$552.00 K$93.37 M-$806.00 K$8.33 M$25.27 M$149.99 M
Change in Cash -$32.13 M$13.78 M-$85.41 M$22.78 M$33.65 M$108.47 M

Cabaletta Bio, Inc. Common Stock Return Calculator

The Cabaletta Bio, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,027
Invested Amount$10,000
Est. Returns$-7,973
Invest in USA Stock Today

About Cabaletta Bio, Inc. Common Stock

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

FAQs

Cabaletta Bio, Inc. Common Stock (CABA) share price as of September 18, 2026 is $2.51. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Cabaletta Bio, Inc. Common Stock (CABA) Share by opening an international trading account with Angel One.
Purchasing Cabaletta Bio, Inc. Common Stock (CABA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cabaletta Bio, Inc. Common Stock (CABA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Cabaletta Bio, Inc. Common Stock (CABA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Cabaletta Bio, Inc. Common Stock on September 18, 2026, is $422.17 M.
Cabaletta Bio, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Cabaletta Bio, Inc. Common Stock (CABA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91